Search

Issue
Title
Authors
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
Antonova K.V., Tanashyan M.M., Maksimova M.Y., Shakhparonova N.V., Romantsova T.I.
Application of Cocarnit in complex treatment of patients with diabetic polyneuropathy in outpatient practice
Novikova L.B., Tarkhanova I.Y., Dmitrieva O.E., Fomichev A.V., Kakaulina L.N.
Potentials for the management of cardiovascular risk in diabetic patients on insulin therapy
Galstyan G.R., Antsiferov M.B., Alekseeva Y.G.
Disturbances of the autonomic innervation of the cardiovascular system and hemostasis: their role in the change of microcirculation in patients with type 2 diabetes mellitus
Tsvetkova I.G., Kaukova A.N., Belyakova N.A., Vasyutkova O.A., Konovalova O.V., Lareva A.V.
Therapy with nonsteroid antiinflammatory drugs in patients with acute nonspecific low back pain: dynamics of renal function: results of «PANDA» cogort study
Zolotovskaya I.A., Davydkin I.L., Borovkova N.Y.
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
Demidov N.A., Antsiferov M.B., Dorofeeva L.G.
Metabolic syndrome and intestinal microbiota
Egshatyan L.V., Mkrtumyan A.M., Zvenigorodskaya L.A.
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
Antsiferov M.B.
Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa
Antsiferov M.B., Nikitina T.P., Rodionova A.Y., Kurbatova K.A., Ionova T.I.
NEBIVOLOL V LEChENII ARTERIAL'NOY GIPERTENZII U BOL'NYKh VYSOKOGO RISKA
Minushkina L.O.
Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa
Biryukova E.V.
KLINIKA, DIAGNOSTIKA I LEChENIE DIABETIChESKOY NEYROPATII
Sharonova L.A., Verbovoy A.F., Sharonova D.Y.
Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa
Ametov A.S., Tertychnaya E.A.
Metabolicheskiy sindrom u bol'nykh sakharnym diabetom i ego korrektsiya preparatami tioktovoy kisloty
Kurnikova I.A.
SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV
Ametov A.S.
Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov
Ruyatkina L.A., Sorokin M.Y.
Rol' taurina i ego defitsita v organizme cheloveka i zhivotnykh
Antsiferov M.B.
Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii
Ametov A.S., Valitov B.I., Chernikova N.A., Antsiferov M.B.
HOW TO OVERCOME THE EFFECTS OF "HYPERGLYCEMIC" MEMORY?
Biryukova E.V., V Biryukova Y.
GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Antsiferov M.B., Antsiferov M.B.
ROLE OF GLYCATION END-PRODUCTS BLOCKERS IN THE DEVELOPMENT OF NEUROLOGIC COMPLICATIONS OF DIABETES MELLITUS
Podachina S.V., Podachina S.V.
RESULTS OF OBSERVATIONAL PROGRAM ON USE OF INSULIN GLARGINE (LANTUS®) IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ROUTINE CLINICAL PRACTICE
Glinkina I.V., Romantsova T.I., Glinkina I.V., Romantsova T.I.
TYPE 2 DIABETES MELLITUS: POTENTIALS FOR ACHIEVEMENT OF OPTIMAL CONTROL WITHOUT SIDE EFFECTS
Antsiferov M.B., Antsiferov M.B.
SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Mkrtumyan A.M., Mkrtumyan A.M.
Verification of the class of carbohydrate metabolism disorders in patients with hyperglycemia first detected on the background of acute coronary syndrome
Golitsyna T.Y., Golitsina T.
Russian consensus on diabetes mellitus therapy in children and adolescents
Dedov I.I., Peterkova V.A., Kuraeva T.L., Dedov I., Peterkova V., Kuraeva T.
SOVREMENNYE PODKhODY K LEChENIYu SAKhARNOGO DIABETA TIPA 2 U MUZhChIN
Tishova Y.A., Kalinichenko S.Y.
Disturbances of lipid metabolism in pregnancy
Tkacheva O.N., Galyautdinova A.Y., Prokhorovich E.A., Mishina I.E., Torshkhoeva K.M., Tkacheva O.N., Galjautdinova A.Y., Prochorovich E.A., Mishina I.E., Torshchoeva C.M.
Metformin - pathogenetic drug of first-line in the treatment of type 2 diabetes
Zilov A.V., Zilov A.V.
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
Pavlova M.G.
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
Antsiferov M.B., Koteshkova O.M., Novikova M.S., Demidov N.A.
What should the practitioner remember when managing patients with diabetic neuropathy
Isakova E.V., Kotov S.V.
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
Morgunova T.B., Fadeyev V.V.
Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?
Abdullaev A.N., Litvinova D.V., Rozhkov N.I., Kiyaev A.V.
Programmed labor for gestational diabetes mellitus - reserve for reducing the frequency of operative delivery
Grabovsky V.M., Kostin I.N., Tazhetdinov E.K.
Hyperglycemia and ischemic stroke: clinical features in patients with type 2 diabetes mellitus
Izhbuldina G.I., Novikova L.B.
Type 1 diabetes mellitus in Moscow -2018 (according to the Moscow segment of the Federal Diabetes Register)
Demidov N.A., Mishra O.A., Antsiferov M.B.
POSSIBILITIES OF METHORMINE IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: TEST OF TIME
Biryukova E.V., Solovyeva I.V., Platonova N.M.
Advantages of switch to premixed insulin degludec/aspart in patients with type 2 diabetes mellitus who have not achieved an optimal control with previous insulin therapy
Elsukova O.S., Sobolev A.A.
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
Statsenko M.E., Turkina S.V., Tyshchenko I.A., Fabritskaya S.V., Poletaeva L.V.
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
Girsh Y.V., Veliyeva O.A.
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety
Antsiferov M.B., Schernthaner G.
DIABETIC ANGIOPATHY «PAINFUL» POINTS: FOCUS ON HYPERTRIGLYCERIDEMIA AND FENOFIBRATE POTENTIAL
Rujatkina L.A., Rujatkin D.S., Zemljanuhina S.A.
10 let ispol'zovaniya pompovoy insulinoterapii v moskovskoy pediatricheskoy praktike -
Rybkina I.G., Petryaykina E.E., Koltunov I.E.
Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem
Antsiferov M.B., Koteshkova O.M.
Primenenie Aktovegina kak universal'nyy metod lecheniya oslozhneniy sakharnogo diabeta
Meleshkevich T.A., Luchina E.I., Lukashova M.E.
Statiny i risk vozniknoveniya novykh sluchaev sakharnogo diabeta: sootnoshenie riska i pol'zy. Sovremennye predstavleniya o tselevykh urovnyakh lipidov u patsientov s sakharnym diabetom
Shalaev S.V., Safiullina Z.M., Mikhal'chuk N.A.
PATOGENETIChESKIE PODKhODY K TERAPII DIABETIChESKOY POLINEVROPATII
Badalyan O.L., Savenkov A.A.
Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa
Ametov A.S.
Effektivnyy i bezopasnyy kontrol' glikemii s pomoshch'yu Diabetona MV: zalog uspeshnoy profilaktiki khronicheskikh oslozhneniy sakharnogo diabeta 2 tipa
Biryukova E.V., Danilova T.B.
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA
Arinina E.E., Rashid M.A., Antsiferov M.B.
Antiagregantnaya terapiya u patsientov s sakharnym diabetom, perenesshikh mozgovoy insul't
Matkevich E.I., Grapov D.O., Maksimov M.L.
Znachenie antioksidantnoy terapii v lechenii diabeticheskoy polinevropatii
Galstyan K.O.
Vliyanie ingibitorov dipeptidilpepti-dazy-4 na funktsional'noe sostoyanie miokarda u bol'nykh sakharnym diabetom 2 tipa
Ametov A.S., Kulidzhanyan N.K., Shurupova I.V., Trifonova T.A., Antsiferov M.B.
TIMELY ADMINISTRATION OF INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS
Chernikova N.A., Prudnikova M.A., Chernikova N.A., Prudnikova M.A.
OSTEOPOROZ: TOChKA ZRENIYa ENDOKRINOLOGA
Biryukova E.V.
DIABETON MB IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS AND PREVENTION OF ITS LATE COMPLICATIONS
Kononenko I.V., Smirnova O.M., Smirnova O.M., Kononenko I.V.
PATHOGENETIC ASPECTS OF TREATMENT OF DISTAL PERIPHERAL POLYNEUROPATHY IN PATIENTS WITH DIABETES MELLITUS
Begma A.N., Begma I.V., Begma A.N., Begma I.V.
ASSESSMENT OF EFFICACY OF EDUCATION OF GENERAL PRACTITIONERS BY THE TRAINING PROGRAM FOR MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Yu Mayorov A., Surkova Y.V., Dedov I.I., Mayorov A.Y., Surkova E.V., Dedov I.I.
ETIOPTHOGENIC ROLE OF INSULIN RESISTANCE IN THE DEVELOPMENT OF METABOLIC AND VASCULAR DISORDERS IN TYPE 2 DIABETES MELLITUS
Demidova T.Y., Demidova T.Y.
New possibilities for type 2 diabetes mellitus therapy. Results of a pilot observation program of efficacy and safety of the drug «Galvus» (vildagliptin) therapy in Moscow and in the regions of the Russian Federation
Pavlova M.G., Pavlova M.
Primenenie bazal'no-bolyusnogo rezhima insulinoterapii u bol'nykh sakharnym diabetom tipa 2
Antsiferov M.B., Morgunov L.Y.
INNOVATsIONNYY KOMBINIROVANNYY PREPARAT GALVUS MET (VILDAGLIPTIN + METFORMIN) V LEChENII SAKhARNOGO DIABETA TIPA 2
Antsiferov M.B.
Bisoprolol in therapy of arterial hypertension and ischemic heart disease
Kirichenko A.A., Kirichenko A.A.
Experience of incritinomimetic exenatide (Byetta) use in the treatment of patients with type 2 diabetes mellitus with obesity
Antsiferov M.B., Koteshkova O.M., Sitnikov V.V., Mityaeva O.A., Pashintseva L.P., Budantseva T.A., Ivanova E.A., Anciferov M.B., Koteshkova O.M., Sitnikov V.V., Mityaeva O.A., Pashinceva L.P., Budanceva T.A., Ivanova E.A.
Features of the pathogenesis and treatment of diabetes mellitus during the COVID-19 pandemic
Bagriy A.E., Mikhailichenko E.S., Prikolota A.V., Mogilevskaya K.E.
Problem of treatment adherence in patients with type 2 diabetes mellitus
Akulova A.D., Zhulina Y.S., Rozhkova V.V., Martynova E.Y., Poteshkin Y.E.
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
Volkova N.I., Panenko S.O., Golubeva A.O.
Testosterone replacement therapy in men with type 2 diabetes mellitus and neuropathy
Zelenina T.A., Salukhov V.V., Zemlyanoy A.B., Chebykina O.E.
The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience
Khamnueva L.Y., Andreeva L.S., Davydova A.V., Chugunova E.V., Tokareva N.P., Molodtsova N.Y.
Modern approaches to using the FreeStyle Libre Flash glucose monitoring system
Demidov N.A., Koteshkova O.M., Antsiferov M.B.
Modern approaches to the choice of hypoglycemic therapy in patients with type 2 diabetes mellitus: a niche of DPP-4 inhibitors
Chernikova N.A., Knyshenko O.A.
Extreme risk category in the stratification of cardiovascular complications. Consensus Council of experts
Expert C.
Experience of the use of insulin degludec in the treatment of patients with type 1 diabetes mellitus (according to the data of the Moscow segment of the Federal Diabetes Register)
Demidov N.A., Mishra O.A., Antsiferov M.B.
Adiponectin and metabolic parameters in patients with type 2 diabetes mellitus and hypothyroidism
Verbovoy A.F., Lomonova T.V., Sharonova L.A.
ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE
Kiyaev A.V., Kondrashova O.E., Chernykh L.G., Pollyak O.Y., Yusupova A.R., Slovak M.A., Zaykova I.O.
Effect of SGLT-2 inhibitors on cardiovascular outcomes: review of results of CVD-REAL trial
Antsiferov M.B.
THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS
Shevkunova N.A.
Features of use of dapagliflozin in thetreatment of patients with type 2 diabetes mellitus
Antsiferov M.B.
OVERVIEW OF PHARMACOECONOMIC STUDIES OF INSULIN PUMP THERAPY IN DIABETES MELLITUS
Tolkushin A.G.
GLYCEMIC VARIABILITY AS A THERAPEUTIC TARGET IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
Ametov A.S., Chernikova N.A., Demidova T.Y., Nazhmutdinova P.K.
Sakharosnizhayushchiy effekt flozinov po sravneniyu s preparatami sul'fonilmocheviny u patsientov s sakharnym diabetom 2 tipa
Galstyan G.R.
Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
Ametov A.S.
Primenenie kombinirovannoy terapii glimepiridom i metforminom u patsientov s sakharnym diabetom 2 tipa. Rezul'taty Rossiyskogo observatsionnogo issledovaniya
Zaytseva N.V., Shamkhalova M.S.
Ispol'zovanie preparatov, proizvedennykh po novym tekhnologiyam, v lechenii nealkogol'nogo steatogepatita
Kazyulin A.N., Babina S.M.
VOZMOZhNOSTI DIBIKORA V KORREKTsII METABOLIChESKIKh I SOSUDISTYKh NARUShENIY U BOL'NYKh KhRONIChESKOY SERDEChNOY NEDOSTATOChNOST'Yu I SAKhARNYM DIABETOM 2 TIPA
Statsenko M.E., Vinnikova A.A., Shilina N.N., Ronskaya A.M.
Farmakoterapiya diabeticheskoy nevropatii: chto eshche krome kontrolya glikemii?
Biryukova E.V., Danilova T.B.
Preparaty tioktovoy kisloty v lechenii erektil'noy disfunktsii u bol'nykh sakharnym diabetom
Kurnikova I.A.
SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA
Verbovoy A.F., Sharonova L.A., Verbovaya N.I., Demidova D.V., Kapishnikov A.V.
Diabeticheskaya retinopatiya i makulyarnyy otek. Algoritmy diagnostiki i lecheniya klinicheski znachimykh form
Shadrichev F.E.
Rannee naznachenie insulina glargin patsientam s sakharnym diabetom 2 tipa, prediabetom i vysokim serdechno-sosudistym riskom: rezul'taty issledovaniya ORIGIN
Antsiferov M.B., Biryukova E.V., Zilov A.V.
Farmakoterapiya, mestnye i dopolnitel'nye metody lecheniya pri sindrome diabeticheskoy stopy
Obolenskiy V.N., Nikitin V.G., Leval' P.S., Ermolova D.A., Molochnikov A.Y., Ermolov A.A.
SUSTAINED-RELEASE METFORMIN (GLUCOPHAGE LONG) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Nikonova T.V., Nikonova T.V.
EVALUATION OF THE CLINICAL AND ECONOMIC EFFICIENCY OF PHARMACOTHERAPY OF DIABETIC POLYNEUROPATHY
Matveev N.V., Matveev N.V.
APPROACHES TO THE TREATMENT OF DIABETES MELLITUS IN ELDERLY PATIENTS: POTENTIALS FOR USE OF INSULIN NOVOMIX 30
Surkova E.V., Surkova E.V.
CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS
Antsiferov M.B., Antsiferov M.B.
POSSIBILITY OF CORRECTION OF OXIDATIVE STRESS IN PATIENTS WITH DIABETES USING DIBICOR
Zanozina O.V., Zanozina O.V.
POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY
Antsiferov M.B., Zilov A.V., Antsiferov M.B., Zilov A.V.
Innovative approaches to the treatment of type 2 diabetes mellitus: the role of specialized product for enteral nutrition "Glucerna SR"
Sharafetdinov K.K., Plotnikova O.A., Sharafetdinov K., Plotnikova O.
Polinevropatii v terapevticheskoy praktike
Erofeeva S.B.
201 - 300 of 343 Items << < 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies